U
VCYT icon

UBS’s Veracyte VCYT Stock Holding History

UBS’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-333
Closed -$6K – 10790
2014
Q2 		$6K Buy
333
+299
+879% +$4.3K ﹤0.01% 9378
2014
Q1 		$1K Buy
+34
New +$543 ﹤0.01% 10232

Other funds holding VCYT

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
GP
Grow Partners San Diego, California $4.81M AUM 7.86% 1-Year Est. Return

UBS's VCYT Position: Q3 2014 in Review

UBS sold out of Veracyte (VCYT) in Q3 2014, closing a stake of 333 shares — an estimated $6K sold.

UBS first reported a position in VCYT in Q1 2014 and held it in 2 quarters. The position peaked at $6K in Q2 2014. 53 funds tracked by Wall St. Rank hold VCYT as of Q3 2014.

  • UBS reported no remaining Veracyte position as of Q3 2014 after selling out during the quarter.
  • UBS sold 333 Veracyte shares in Q3 2014, an estimated $6K.
  • UBS first reported a position in Veracyte in Q1 2014 and held it in 2 quarters.
  • UBS's Veracyte position peaked at $6K in Q2 2014.
  • 53 funds tracked by Wall St. Rank held Veracyte as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.